Bio-Techne TECH Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| —— | $168.11M-41.1% | $285.44M+8.5% | $263.1M+88.5% | ||
| $109.9M-1.6% | $111.71M+4.2% | $107.24M+6.1% | $101.07M+15.2% | ||
| $40.83M+7.3% | $38.04M-7.9% | $41.32M-2.1% | $42.18M-13.9% | ||
| -$51.11M-29.6% | -$39.45M-33.4% | -$29.57M— | —— | ||
| $18.32M+28.9% | $14.22M-52.9% | $30.17M-5.7% | $32.01M— | ||
| —— | $25.77M— | —— | $12.74M-61.3% | ||
| $15.41M+22.1% | $12.62M— | —— | $7.76M-62.2% | ||
| —— | —— | -$17K— | —— | ||
| —— | —— | —— | —— | ||
| $8.47M— | —— | -$2.49M-193% | $2.67M-80.8% | ||
| —— | —— | -$1.14M— | —— | ||
| —— | $20.53M-1.6% | $20.87M-65.8% | $60.93M— | ||
| $287.56M-3.8% | $298.98M+17.5% | $254.39M-21.8% | $325.27M-7.6% | ||
| $31.01M-50.7% | $62.88M+64.4% | $38.24M-14.8% | $44.91M+1.4% | ||
| —— | —— | $35.24M— | —— | ||
| —— | —— | $232M— | —— | ||
| -$35.59M+82.5% | -$203.03M+23.6% | -$265.65M-174% | -$96.85M+60.2% | ||
| $50.39M-0.1% | $50.42M+0.3% | $50.29M+0.2% | $50.19M+1.1% | ||
| —— | $80.04M— | —— | —— | ||
| $77M-69.9% | $256M-51.3% | $525.66M+200% | $175.5M-35.4% | ||
| $51.74M-15.1% | $60.94M+104% | $29.81M-61.4% | $77.16M+18.5% | ||
| $6.52M-70.2% | $21.87M-24.3% | $28.89M+23.2% | $23.46M+21.3% | ||
| -$253.91M-107% | -$122.4M— | —— | -$242.85M— | ||
| $11.93M— | —— | —— | —— | ||
| —— | —— | $8M— | —— | ||
| —— | $14.5M+73.3% | $8.37M-24.1% | $11.03M— | ||
| —— | —— | —— | —— | ||
| $21.31M— | —— | —— | —— | ||
| $938K+114% | -$6.84M-499% | -$1.14M— | —— | ||
| $751K+3.0% | $729K— | —— | —— | ||
| —— | $20.53M-1.6% | $20.87M-65.8% | $60.93M— | ||
| $15.41M+22.1% | $12.62M— | —— | $7.76M-62.2% | ||
| —— | —— | —— | —— | ||
| $685K-62.6% | $1.83M— | —— | -$1.2M— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | $35.24M+35.2% | $26.06M— | ||
| —— | —— | —— | —— | ||
| $7.29M+4.2% | $7M+103% | -$232M— | —— | ||
| $11.93M— | —— | —— | —— | ||
| —— | —— | —— | $90M-64.8% | ||
| —— | —— | —— | —— | ||
| $256.55M+8.7% | $236.1M+9.2% | $216.15M-22.9% | $280.36M-8.9% | ||
| $256.55M+8.7% | $236.1M+9.2% | $216.15M-22.9% | $280.36M-8.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Bio-Techne generate?
- Bio-Techne (TECH) generated $294.9M in operating cash flow over the trailing twelve months.
- What is Bio-Techne's free cash flow?
- After $25.3M of capital expenditures, Bio-Techne's free cash flow was $269.6M over the trailing twelve months, up 22.1% year over year.
- Where does Bio-Techne's cash flow data come from?
- Every line is extracted from Bio-Techne's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
